Stepan Company is regaining momentum after a challenging start to the year, driven by strong margin recovery and robust growth in volume and pricing across its core segments. The company's pass-through mechanisms and Project Catalyst cost savings have significantly improved EBIT and net income despite volatile feedstock costs. North American sales, especially in surfactants and polymers used in data center construction, are growing faster than global markets, expanding Stepan's market share. The company is rated a Buy with an expected 11.2% upside by 2028, supported by sustainable dividends, attractive valuation, and effective cost and growth strategies.
Stepan Company is the subject of this update, with Pluang providing a snapshot of the Basic Materials sector as of Sep 29, 2026 00:02 WIB. Out of 38 priced US stocks in this sector, only 6 rose while 32 fell. Notably, Barrick Gold Corp (B) declined 4.01% to USD 41.16 with a typical hold time of 54 days, Kinross Gold Corporation (KGC) dropped 3.71% to USD 24.12 with a 52-day hold, and Albemarle Corp. (ALB) fell 2.77% to USD 106.69 with a 50-day hold time, illustrating a broadly negative day for the sector.
Interlink Electronics announced a 3.4% revenue increase to $3.06 million for Q3 2026 and a 9.6% rise to $9.9 million for the first nine months of 2026, driven by higher shipments of force-sensing and gas-sensor products. The company reported a net lo...
ALS Canada, with renewed funding from TD Bank, is advancing its national strategy for ALS genetics to enhance access to genetic information, counselling, and care for Canadians affected by or at risk of ALS. This builds on the 2024 pilot of the first...
The Canadian ALS Society has renewed funding from TD Bank to expand its national genetics strategy for ALS, improving access to genetic information, counseling, and care for those affected or at risk. This initiative builds on a pilot project that cr...
CollPlant Biotechnologies will change its Nasdaq ticker from CLGN to OPHI starting November 13, 2026, reflecting its strategic shift toward photonic computing through its subsidiary LightSolver. This move highlights CollPlant's focus on developing Li...
Evaxion, a clinical-stage TechBio company, has released its financial calendar for 2027, outlining important dates for business updates and financial results. Key events include the full year 2026 results on March 4, the Annual General Meeting on Apr...
